Serenoa repens for benign prostatic hyperplasia.
- 2012-12-12
- Meta-Analysis · n = 5,666
- The Cochrane database of systematic reviews 12
- James Tacklind
- Roderick Macdonald
- Indy Rutks
- Judith U Stanke
- Timothy J Wilt
- PubMed: 23235581
- DOI: 10.1002/14651858.cd001423.pub3
- High evidence
- Clinical
no significant difference between SR and placebo (MD -1.22 cc, 95% CI -3.91 to 1.47).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- not specified for this outcome (one high quality 12-month trial)